# Genalyte

> Genalyte, Inc. is a San Diego, California in-vitro diagnostics company building point-of-care
> blood testing systems on silicon photonic microring resonator technology. Its Merlin analyzer —
> successor to the Maverick Diagnostic System — runs hematology, chemistry and immunoassay panels
> from small whole-blood or serum volumes and returns results in roughly 20–30 minutes, with a
> cloud verification layer (marketed as CloudLab) that routes results into electronic medical
> record systems.

**Genalyte publishes no public API.** As of 2026-08-04 there is no developer portal, no API
documentation, no OpenAPI/AsyncAPI/GraphQL specification, no SDK, no MCP server, and no A2A agent
card on any Genalyte host. The `api.genalyte.com`, `cloudlab.genalyte.com` and `lab.genalyte.com`
hostnames exist in DNS but are dangling CNAMEs that resolve to no address. EMR integration is
described in marketing material but no interface specification is published.

This file was generated by the API Evangelist enrichment pipeline on 2026-08-04 from Genalyte's
public website. method: generated. It is a third-party profile, not a Genalyte publication.

## Company

- [Genalyte](https://www.genalyte.com/): Company homepage.
- [About Genalyte](https://www.genalyte.com/about-genalyte): Mission, leadership, board, San Diego HQ.
- [Science](https://www.genalyte.com/science): Silicon photonic microring resonator detection technology.
- [Use Cases](https://www.genalyte.com/use-cases): Clinical settings the Merlin system targets.
- [Hospitals & Health Systems](https://www.genalyte.com/hospitals-health-systems): Health system positioning.
- [Government, Military & VA](https://www.genalyte.com/government-military-va): Public sector positioning.
- [Careers](https://www.genalyte.com/careers): Open roles.
- [Contact](https://www.genalyte.com/contact-us): Contact form; info@genalyte.com.

## News and research

- [News](https://www.genalyte.com/news): Company announcements and press coverage.
- [Publications](https://www.genalyte.com/publications): Peer-reviewed papers on the microring resonator platform.
- [FDA clears silicon chip based blood test](https://www.genalyte.com/post/fda-clears-silicon-chip-based-blood-test): 2024-07-22 TSH immunoassay clearance.

## Legal and compliance

- [Privacy Policy](https://www.genalyte.com/legal/privacy-policy): Effective 2020-11-25; references HIPAA and CCPA.
- [Terms of Use](https://www.genalyte.com/legal/terms-of-use): Effective 2020-11-25.
- [Notice of Privacy Practices](https://www.genalyte.com/legal/notice-of-privacy-practices): HIPAA/HITECH covered-entity notice.

## API Evangelist profile artifacts

- [apis.yml](https://raw.githubusercontent.com/api-evangelist/genalyte/refs/heads/main/apis.yml): APIs.json 0.20 profile.
- [Conformance](https://raw.githubusercontent.com/api-evangelist/genalyte/refs/heads/main/conformance/genalyte-conformance.yml): Standards and regulatory posture, evidence-linked.
- [Domain security](https://raw.githubusercontent.com/api-evangelist/genalyte/refs/heads/main/security/genalyte-domain-security.yml): TLS, HSTS, DNSSEC, CAA, SPF, DMARC probe results.
- [Well-known probe](https://raw.githubusercontent.com/api-evangelist/genalyte/refs/heads/main/well-known/genalyte-well-known.yml): Discovery-path probe record (no documents found).

## Optional

- [Genalyte on LinkedIn](https://www.linkedin.com/company/genalyte-inc/)
- [Genalyte on X](https://x.com/Genalyte/)
- [Genalyte secondary-market listing](https://forgeglobal.com/genalyte_stock/): Forge Global private-market page.